Insulet Corporation (PODD): Price and Financial Metrics

Insulet Corporation (PODD)

Today's Latest Price: $223.72 USD

1.20 (0.54%)

Updated Sep 17 6:55pm

Add PODD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 138 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

PODD Stock Summary

  • PODD's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,326.95 -- higher than 97.35% of US-listed equities with positive expected earnings growth.
  • PODD's current price/earnings ratio is 810.56, which is higher than 99.08% of US stocks with positive earnings.
  • The price/operating cash flow metric for Insulet Corp is higher than 97.71% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Insulet Corp, a group of peers worth examining would be ENTG, SCL, SUPN, LOGI, and MKSI.
  • PODD's SEC filings can be seen here. And to visit Insulet Corp's official web site, go to
PODD Daily Price Range
PODD 52-Week Price Range

PODD Stock Price Chart Technical Analysis Charts

PODD Price/Volume Stats

Current price $223.72 52-week high $233.99
Prev. close $222.52 52-week low $121.00
Day low $218.46 Volume 507,400
Day high $224.34 Avg. volume 558,896
50-day MA $208.41 Dividend yield N/A
200-day MA $191.62 Market Cap 14.69B

Insulet Corporation (PODD) Company Bio

Insulet Corporation develops, manufactures, and sells insulin infusion systems for people with insulin-dependent diabetes in the United States. The company was founded in 2000 and is based in Billerica, Massachusetts.

PODD Latest News Stream

Event/Time News Detail
Loading, please wait...

PODD Latest Social Stream

Loading social stream, please wait...

View Full PODD Social Stream

Latest PODD News From Around the Web

Below are the latest news stories about Insulet Corp that investors may wish to consider to help them evaluate PODD as an investment opportunity.

Hedge Funds Never Been This Bullish On Insulet Corporation (PODD)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the second quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | September 7, 2020

Why Is Insulet (PODD) Down 7.1% Since Last Earnings Report?

Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 5, 2020

Insulet Shows Market Leadership With Jump To 82 RS Rating

The RS rating means that Insulet stock has outperformed 82% of all stocks over the past 12 months. Over 100 years of market history shows that the best-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves. In addition to its strong RS rating, Insulet boasts an 87 Composite Rating, and a B+ Accumulation/Distribution Rating on an A-E scale with A tops.

Yahoo | September 1, 2020

Insulet (PODD) Banks on Omnipod Uptake Amid Coronavirus Woes

Insulet (PODD) adds significant capacity in preparation for the Omnipod 5 launch in 2021.

Yahoo | August 25, 2020

Insulet to Present at Upcoming Investor Conferences

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two virtual investor conferences: The Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020, at 12:15 p.m. (Eastern Time) The Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14, 2020, at 9:45 a.m. (Eastern Time) To listen to liv

Business Wire | August 24, 2020

Read More 'PODD' Stories Here

PODD Price Returns

1-mo 6.66%
3-mo 12.13%
6-mo 56.89%
1-year 46.62%
3-year 284.27%
5-year 641.53%
YTD 30.68%
2019 115.83%
2018 14.96%
2017 83.12%
2016 -0.34%
2015 -17.91%

Continue Researching PODD

Here are a few links from around the web to help you further your research on Insulet Corp's stock as an investment opportunity:

Insulet Corp (PODD) Stock Price | Nasdaq
Insulet Corp (PODD) Stock Quote, History and News - Yahoo Finance
Insulet Corp (PODD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7884 seconds.